Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Human Immunodeficiency Virus(HIV) Market Size Growth Rate by Type (2014-2025) 1.4.2 Diagnosis 1.4.3 Treatment 1.5 Market by Application 1.5.1 Global Human Immunodeficiency Virus(HIV) Market Share by Application (2014-2025) 1.5.2 Hospitals 1.5.3 Ambulatory Surgical Centers 1.5.4 Diagnostic Centers 1.5.5 Homecare Settings 1.5.6 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Human Immunodeficiency Virus(HIV) Market Size 2.2 Human Immunodeficiency Virus(HIV) Growth Trends by Regions 2.2.1 Human Immunodeficiency Virus(HIV) Market Size by Regions (2014-2025) 2.2.2 Human Immunodeficiency Virus(HIV) Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Human Immunodeficiency Virus(HIV) Market Size by Manufacturers 3.1.1 Global Human Immunodeficiency Virus(HIV) Revenue by Manufacturers (2014-2019) 3.1.2 Global Human Immunodeficiency Virus(HIV) Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Human Immunodeficiency Virus(HIV) Market Concentration Ratio (CR5 and HHI) 3.2 Human Immunodeficiency Virus(HIV) Key Players Head office and Area Served 3.3 Key Players Human Immunodeficiency Virus(HIV) Product/Solution/Service 3.4 Date of Enter into Human Immunodeficiency Virus(HIV) Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Human Immunodeficiency Virus(HIV) Market Size by Type (2014-2019) 4.2 Global Human Immunodeficiency Virus(HIV) Market Size by Application (2014-2019) 5 United States 5.1 United States Human Immunodeficiency Virus(HIV) Market Size (2014-2019) 5.2 Human Immunodeficiency Virus(HIV) Key Players in United States 5.3 United States Human Immunodeficiency Virus(HIV) Market Size by Type 5.4 United States Human Immunodeficiency Virus(HIV) Market Size by Application 6 Europe 6.1 Europe Human Immunodeficiency Virus(HIV) Market Size (2014-2019) 6.2 Human Immunodeficiency Virus(HIV) Key Players in Europe 6.3 Europe Human Immunodeficiency Virus(HIV) Market Size by Type 6.4 Europe Human Immunodeficiency Virus(HIV) Market Size by Application 7 China 7.1 China Human Immunodeficiency Virus(HIV) Market Size (2014-2019) 7.2 Human Immunodeficiency Virus(HIV) Key Players in China 7.3 China Human Immunodeficiency Virus(HIV) Market Size by Type 7.4 China Human Immunodeficiency Virus(HIV) Market Size by Application 8 Japan 8.1 Japan Human Immunodeficiency Virus(HIV) Market Size (2014-2019) 8.2 Human Immunodeficiency Virus(HIV) Key Players in Japan 8.3 Japan Human Immunodeficiency Virus(HIV) Market Size by Type 8.4 Japan Human Immunodeficiency Virus(HIV) Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Human Immunodeficiency Virus(HIV) Market Size (2014-2019) 9.2 Human Immunodeficiency Virus(HIV) Key Players in Southeast Asia 9.3 Southeast Asia Human Immunodeficiency Virus(HIV) Market Size by Type 9.4 Southeast Asia Human Immunodeficiency Virus(HIV) Market Size by Application 10 India 10.1 India Human Immunodeficiency Virus(HIV) Market Size (2014-2019) 10.2 Human Immunodeficiency Virus(HIV) Key Players in India 10.3 India Human Immunodeficiency Virus(HIV) Market Size by Type 10.4 India Human Immunodeficiency Virus(HIV) Market Size by Application 11 Central & South America 11.1 Central & South America Human Immunodeficiency Virus(HIV) Market Size (2014-2019) 11.2 Human Immunodeficiency Virus(HIV) Key Players in Central & South America 11.3 Central & South America Human Immunodeficiency Virus(HIV) Market Size by Type 11.4 Central & South America Human Immunodeficiency Virus(HIV) Market Size by Application 12 International Players Profiles 12.1 Gilead 12.1.1 Gilead Company Details 12.1.2 Company Description and Business Overview 12.1.3 Human Immunodeficiency Virus(HIV) Introduction 12.1.4 Gilead Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019) 12.1.5 Gilead Recent Development 12.2 GlaxoSmithKline 12.2.1 GlaxoSmithKline Company Details 12.2.2 Company Description and Business Overview 12.2.3 Human Immunodeficiency Virus(HIV) Introduction 12.2.4 GlaxoSmithKline Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019) 12.2.5 GlaxoSmithKline Recent Development 12.3 Johnson & Johnson 12.3.1 Johnson & Johnson Company Details 12.3.2 Company Description and Business Overview 12.3.3 Human Immunodeficiency Virus(HIV) Introduction 12.3.4 Johnson & Johnson Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019) 12.3.5 Johnson & Johnson Recent Development 12.4 Merck 12.4.1 Merck Company Details 12.4.2 Company Description and Business Overview 12.4.3 Human Immunodeficiency Virus(HIV) Introduction 12.4.4 Merck Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019) 12.4.5 Merck Recent Development 12.5 AbbVie 12.5.1 AbbVie Company Details 12.5.2 Company Description and Business Overview 12.5.3 Human Immunodeficiency Virus(HIV) Introduction 12.5.4 AbbVie Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019) 12.5.5 AbbVie Recent Development 12.6 Bristol-Myers Squibb 12.6.1 Bristol-Myers Squibb Company Details 12.6.2 Company Description and Business Overview 12.6.3 Human Immunodeficiency Virus(HIV) Introduction 12.6.4 Bristol-Myers Squibb Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019) 12.6.5 Bristol-Myers Squibb Recent Development 12.7 Boehringer Ingelheim 12.7.1 Boehringer Ingelheim Company Details 12.7.2 Company Description and Business Overview 12.7.3 Human Immunodeficiency Virus(HIV) Introduction 12.7.4 Boehringer Ingelheim Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019) 12.7.5 Boehringer Ingelheim Recent Development 12.8 Genentech 12.8.1 Genentech Company Details 12.8.2 Company Description and Business Overview 12.8.3 Human Immunodeficiency Virus(HIV) Introduction 12.8.4 Genentech Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019) 12.8.5 Genentech Recent Development 12.9 Cipla 12.9.1 Cipla Company Details 12.9.2 Company Description and Business Overview 12.9.3 Human Immunodeficiency Virus(HIV) Introduction 12.9.4 Cipla Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019) 12.9.5 Cipla Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Human Immunodeficiency Virus(HIV) Key Market Segments Table Key Players Human Immunodeficiency Virus(HIV) Covered Table Global Human Immunodeficiency Virus(HIV) Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Human Immunodeficiency Virus(HIV) Market Size Market Share by Type 2014-2025 Figure Diagnosis Figures Table Key Players of Diagnosis Figure Treatment Figures Table Key Players of Treatment Table Global Human Immunodeficiency Virus(HIV) Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals Case Studies Figure Ambulatory Surgical Centers Case Studies Figure Diagnostic Centers Case Studies Figure Homecare Settings Case Studies Figure Others Case Studies Figure Human Immunodeficiency Virus(HIV) Report Years Considered Table Global Human Immunodeficiency Virus(HIV) Market Size 2014-2025 (Million US$) Figure Global Human Immunodeficiency Virus(HIV) Market Size and Growth Rate 2014-2025 (Million US$) Table Global Human Immunodeficiency Virus(HIV) Market Size by Regions 2014-2025 (Million US$) Table Global Human Immunodeficiency Virus(HIV) Market Size by Regions 2014-2019 (Million US$) Table Global Human Immunodeficiency Virus(HIV) Market Share by Regions 2014-2019 Figure Global Human Immunodeficiency Virus(HIV) Market Share by Regions 2014-2019 Figure Global Human Immunodeficiency Virus(HIV) Market Share by Regions 2019 Table Market Top Trends Table Global Human Immunodeficiency Virus(HIV) Revenue by Manufacturers (2014-2019) (Million US$) Table Global Human Immunodeficiency Virus(HIV) Market Share by Manufacturers (2014-2019) Figure Global Human Immunodeficiency Virus(HIV) Market Share by Manufacturers in 2018 Table Global Human Immunodeficiency Virus(HIV) Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Human Immunodeficiency Virus(HIV) Product/Solution/Service Table Date of Enter into Human Immunodeficiency Virus(HIV) Market Table Mergers & Acquisitions, Expansion Plans Table Global Human Immunodeficiency Virus(HIV) Market Size by Type (2014-2019) (Million US$) Table Global Human Immunodeficiency Virus(HIV) Market Size Share by Type (2014-2019) Figure Global Human Immunodeficiency Virus(HIV) Market Size Market Share by Type (2014-2019) Table Global Human Immunodeficiency Virus(HIV) Market Size by Application (2014-2019) (Million US$) Table Global Human Immunodeficiency Virus(HIV) Market Size Share by Application (2014-2019) Figure Global Human Immunodeficiency Virus(HIV) Market Size Market Share by Application (2014-2019) Figure Global Human Immunodeficiency Virus(HIV) Revenue Market Share by Application in 2018 Figure United States Human Immunodeficiency Virus(HIV) Market Size 2014-2019 (Million US$) Table United States Key Players Human Immunodeficiency Virus(HIV) Revenue (2018-2019) (Million US$) Table United States Key Players Human Immunodeficiency Virus(HIV) Market Share (2018-2019) Table United States Human Immunodeficiency Virus(HIV) Market Size by Type (2014-2019) (Million US$) Table United States Human Immunodeficiency Virus(HIV) Market Share by Type (2014-2019) Table United States Human Immunodeficiency Virus(HIV) Market Size by Application (2014-2019) (Million US$) Table United States Human Immunodeficiency Virus(HIV) Market Share by Application (2014-2019) Figure Europe Human Immunodeficiency Virus(HIV) Market Size 2014-2019 (Million US$) Table Europe Key Players Human Immunodeficiency Virus(HIV) Revenue (2018-2019) (Million US$) Table Europe Key Players Human Immunodeficiency Virus(HIV) Market Share (2018-2019) Table Europe Human Immunodeficiency Virus(HIV) Market Size by Type (2014-2019) (Million US$) Table Europe Human Immunodeficiency Virus(HIV) Market Share by Type (2014-2019) Table Europe Human Immunodeficiency Virus(HIV) Market Size by Application (2014-2019) (Million US$) Table Europe Human Immunodeficiency Virus(HIV) Market Share by Application (2014-2019) Figure China Human Immunodeficiency Virus(HIV) Market Size 2014-2019 (Million US$) Table China Key Players Human Immunodeficiency Virus(HIV) Revenue (2018-2019) (Million US$) Table China Key Players Human Immunodeficiency Virus(HIV) Market Share (2018-2019) Table China Human Immunodeficiency Virus(HIV) Market Size by Type (2014-20189) (Million US$) Table China Human Immunodeficiency Virus(HIV) Market Share by Type (2014-2019) Table China Human Immunodeficiency Virus(HIV) Market Size by Application (2014-2019) (Million US$) Table China Human Immunodeficiency Virus(HIV) Market Share by Application (2014-2019) Figure Japan Human Immunodeficiency Virus(HIV) Market Size 2014-2019 (Million US$) Table Japan Key Players Human Immunodeficiency Virus(HIV) Revenue (2018-2019) (Million US$) Table Japan Key Players Human Immunodeficiency Virus(HIV) Market Share (2018-2019) Table Japan Human Immunodeficiency Virus(HIV) Market Size by Type (2014-2019) (Million US$) Table Japan Human Immunodeficiency Virus(HIV) Market Share by Type (2014-2019) Table Japan Human Immunodeficiency Virus(HIV) Market Size by Application (2014-2019) (Million US$) Table Japan Human Immunodeficiency Virus(HIV) Market Share by Application (2014-2019) Figure Southeast Asia Human Immunodeficiency Virus(HIV) Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Human Immunodeficiency Virus(HIV) Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Human Immunodeficiency Virus(HIV) Market Share (2018-2019) Table Southeast Asia Human Immunodeficiency Virus(HIV) Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Human Immunodeficiency Virus(HIV) Market Share by Type (2014-2019) Table Southeast Asia Human Immunodeficiency Virus(HIV) Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Human Immunodeficiency Virus(HIV) Market Share by Application (2014-2019) Figure India Human Immunodeficiency Virus(HIV) Market Size 2014-2019 (Million US$) Table India Key Players Human Immunodeficiency Virus(HIV) Revenue (2018-2019) (Million US$) Table India Key Players Human Immunodeficiency Virus(HIV) Market Share (2018-2019) Table India Human Immunodeficiency Virus(HIV) Market Size by Type (2014-2019) (Million US$) Table India Human Immunodeficiency Virus(HIV) Market Share by Type (2014-2019) Table India Human Immunodeficiency Virus(HIV) Market Size by Application (2014-2019) (Million US$) Table India Human Immunodeficiency Virus(HIV) Market Share by Application (2014-2019) Figure Central & South America Human Immunodeficiency Virus(HIV) Market Size 2014-2019 (Million US$) Table Central & South America Key Players Human Immunodeficiency Virus(HIV) Revenue (2018-2019) (Million US$) Table Central & South America Key Players Human Immunodeficiency Virus(HIV) Market Share (2018-2019) Table Central & South America Human Immunodeficiency Virus(HIV) Market Size by Type (2014-2019) (Million US$) Table Central & South America Human Immunodeficiency Virus(HIV) Market Share by Type (2014-2019) Table Central & South America Human Immunodeficiency Virus(HIV) Market Size by Application (2014-2019) (Million US$) Table Central & South America Human Immunodeficiency Virus(HIV) Market Share by Application (2014-2019) Table Gilead Company Details Table Gilead Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019) (Million US$) Figure Gilead Revenue Growth Rate in Human Immunodeficiency Virus(HIV) Business (2014-2019) Table Gilead Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)(Million US$) Figure GlaxoSmithKline Revenue Growth Rate in Human Immunodeficiency Virus(HIV) Business (2014-2019) Table GlaxoSmithKline Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)(Million US$) Figure Johnson & Johnson Revenue Growth Rate in Human Immunodeficiency Virus(HIV) Business (2014-2019) Table Johnson & Johnson Recent Development Table Merck Company Details Table Merck Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)(Million US$) Figure Merck Revenue Growth Rate in Human Immunodeficiency Virus(HIV) Business (2014-2019) Table Merck Recent Development Table AbbVie Company Details Table AbbVie Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)(Million US$) Figure AbbVie Revenue Growth Rate in Human Immunodeficiency Virus(HIV) Business (2014-2019) Table AbbVie Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)(Million US$) Figure Bristol-Myers Squibb Revenue Growth Rate in Human Immunodeficiency Virus(HIV) Business (2014-2019) Table Bristol-Myers Squibb Recent Development Table Boehringer Ingelheim Company Details Table Boehringer Ingelheim Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)(Million US$) Figure Boehringer Ingelheim Revenue Growth Rate in Human Immunodeficiency Virus(HIV) Business (2014-2019) Table Boehringer Ingelheim Recent Development Table Genentech Company Details Table Genentech Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)(Million US$) Figure Genentech Revenue Growth Rate in Human Immunodeficiency Virus(HIV) Business (2014-2019) Table Genentech Recent Development Table Cipla Company Details Table Cipla Revenue in Human Immunodeficiency Virus(HIV) Business (2014-2019)(Million US$) Figure Cipla Revenue Growth Rate in Human Immunodeficiency Virus(HIV) Business (2014-2019) Table Cipla Recent Development Table Global Human Immunodeficiency Virus(HIV) Market Size by Regions (Million US$) 2019-2025 Figure Global Human Immunodeficiency Virus(HIV) Market Size Share by Regions (2019-2025) Figure Global Human Immunodeficiency Virus(HIV) Market Size Share by Regions in 2025 Figure United States Human Immunodeficiency Virus(HIV) Market Size Forecast (2019-2025)(Million USD) Figure Europe Human Immunodeficiency Virus(HIV) Market Size Forecast (2019-2025)(Million USD) Figure China Human Immunodeficiency Virus(HIV) Market Size Forecast (2019-2025)(Million USD) Figure Japan Human Immunodeficiency Virus(HIV) Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Human Immunodeficiency Virus(HIV) Market Size Forecast (2019-2025)(Million USD) Figure India Human Immunodeficiency Virus(HIV) Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Human Immunodeficiency Virus(HIV) Market Size Forecast (2019-2025)(Million USD) Table Global Human Immunodeficiency Virus(HIV) Market Size by Product (2019-2025) (Million US$) Figure Global Human Immunodeficiency Virus(HIV) Market Size by Product (2019-2025) Figure Global Human Immunodeficiency Virus(HIV) Market Size by Product in 2025 Table Global Human Immunodeficiency Virus(HIV) Market Size by Application (2019-2025) (Million US$) Figure Global Human Immunodeficiency Virus(HIV) Market Size by Application (2019-2025) Figure Global Human Immunodeficiency Virus(HIV) Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Gilead GlaxoSmithKline Johnson & Johnson Merck AbbVie Bristol-Myers Squibb Boehringer Ingelheim Genentech Cipla